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Abstract
Background and Purpose—The implementation of uniform nomenclature and classification
in adult arterial ischemic stroke (AIS) has been critical for defining outcomes and recurrence risks
according to etiology and in developing risk-stratified treatments. In contrast, current classification
and nomenclature in childhood AIS are often overlapping or contradictory. Our purpose was to
develop a comprehensive consensus-based classification system for childhood AIS.
Methods—Utilizing a modified-Delphi method, members of the International Pediatric Stroke
Study (IPSS) developed the Childhood AIS Standardized Classification and Diagnostic Evaluation
(CASCADE) criteria. Two groups of pediatric stroke specialists from the IPSS classified seven
test cases using two methods each: 1) classification typical of the individual clinician’s current
clinical practice, 2) classification based on the CASCADE criteria. Group 1 underwent in-person
training in the utilization of the CASCADE criteria. Group 2 classified the same cases via an
online survey including definitions but without training. Inter-rater reliability (IRR) was assessed
via multi-rater unweighted kappa statistic.
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Results—In Group 1 (with training), IRR was improved using CASCADE criteria (κ=0.78, 95%
CI=[0.49, 0.94]) compared to typical clinical practice (κ=0.40, 95%CI=[0.11, 0.60]). In Group 2
(without training), IRR was lower than among trained raters, (κ=0.61, 95%CI=[0.29,0.77]); but
higher than current practice (κ=0.23, 95%CI=[0.03,0.36]).
Conclusions—A new, consensus-based classification system for childhood AIS, the CASCADE
criteria, can be used to classify cases with good IRR. These preliminary findings suggest that the
CASCADE criteria may be particularity useful in the setting of prospective multicenter studies in
childhood-onset AIS, where standardized training of investigators is feasible.
Introduction
The adoption of uniform nomenclature and a validated classification system in arterial
ischemic stroke (AIS) in adults has been critical to the study of neurological outcomes, risk
stratified therapies and recurrence risk.1;2 Multiple classification systems exist for adult AIS
that have been validated and utilized for the purposes of multi-center collaborative efforts.
As an example, the TOAST classification system has been utilized in over 180 peer-
reviewed publications in adult stroke, facilitating the study of differences in adult stroke
subtypes with respect to etiology, risk factors (including genetic polymorphisms), treatment,
and outcomes.3-5 Utilization of the TOAST criteria has, in turn, led to the development and
successful conduct of clinical trials evaluating risk-stratified approaches to treatment in adult
AIS.
Over the past decade, collaborative groups have made considerable progress in
understanding the epidemiology, etiology, pathophysiology, outcomes, and prognostic
factors in childhood AIS.6-9 Nevertheless, current research efforts are hampered by the lack
of standardized nomenclature and classification in the childhood form of this disease.10-12
Initial attempts at classification in childhood AIS utilizing adult criteria found that the
majority of children with AIS do not meet criteria for atherothrombotic, cardio-embolic or
small-vessel disease, as seen in adults.13;14 Subsequent efforts toward childhood-specific
nomenclature and classification in AIS have been proposed (The Pediatric Stroke
Classification [PSC] and the Sebire Criteria), but no one system has been widely
adopted.15;16
The PSC was created by adding subtypes that were identified in the literature to selected
subtypes from the TOAST criteria.15 Although the system has good IRR, with ICC=0.92, it
has not been widely adopted in the childhood stroke literature, possibly due to the lack of
consensus development, overlap with the Sebire criteria nomenclature and inability to
classify changes in arteriopathy over time. Although the Sebire criteria are consensus-based,
the authors did not attempt to categorize strokes of non-vascular etiology, making it an
incomplete system for classification.16 In addition, these two systems also have overlapping
and sometimes contradictory nomenclature, especially in regard to arteriopathies which are
common in childhood AIS. The pediatric rheumatology literature provides additional
definitions for inflammatory arteriopathies by adapting the adult Calabrese criteria for
primary angiitis of the nervous system (PACNS), which have even further potential overlap
with the Sebire and PSC definitions for arteriopathy.17;18
In order to devise a consensus-based classification system and uniform nomenclature for
childhood AIS, the International Pediatric Stroke Study (IPSS) established a working group
in childhood AIS classification in November 2007. The objectives of this report are to
describe the methodology utilized to develop the Childhood AIS Standardized Classification
and Diagnostic Evaluation (CASCADE) criteria, and to provide evidence of inter-rater
reliability using this new, comprehensive classification system in childhood AIS.
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The IPSS is an international research network that created a registry of patients with
pediatric cerebrovascular disease, established in 2003 with the long-term goal of developing
multinational clinical trials in pediatric ischemic stroke.7;19 Investigators of the IPSS created
a working group to construct a consensus-based classification system for childhood AIS.
The working group consisted of fourteen volunteers from the IPSS: ten pediatric
neurologists, one adult neurologist, two pediatric hematologists and one pediatric
rheumatologist. The initial version of the CASCADE criteria represented a compilation of
criteria from three published systems: The Pediatric Stroke Classification (PSC),15 the
Sebire definitions for cerebral arteriopathy16 and Calabrese criteria for childhood primary
CNS vasculitis.17;20;21 In subsequent versions, the working group established a unifying
theme for the new classification system: an anatomically based system. In order to minimize
subjectivity, the primary classification is largely based upon objective anatomic evidence of
any identifiable disease contributing to stroke causation, including disorders of the heart,
cervical and intracranial vasculature.
The CASCADE criteria was revised utilizing a modified-Delphi method (Figure 1).22;23
Each revision incorporated critiques solicited from members of the working group regarding
the clinical relevance and conceptual validity of the overall system as well as each subtype.
The co-chairs (TB & RI) evaluated all responses and incorporated the critiques and
suggestions into the next revision. Reviewers were asked to specify their assessments as: 1)
Agreement, 2) Agreement with minor modifications, or 3) Disagreement. In addition, there
was a section provided for additional comments and suggested revisions. The proposal for
the CASCADE criteria underwent four revisions. When disagreements arose, the working
group was polled regarding possible solutions, and the majority opinion was accepted.
Based upon this consensus-driven process, the 4th revision was presented to the IPSS
members attending the IPSS investigators’ meeting in February, 2009. After a 20 minute
training session, seven childhood stroke vignettes were presented to the membership by the
working group chairs, and the IPSS members in attendance were asked to classify the cases
using two methods: 1) the approach typical of the clinician’s current practice, via entry of
free text (Individual Classification), and 2) the CASCADE criteria. Group 1 was comprised
of the six members who volunteered to classify all seven cases. Each vignette was based on
real cases selected from stroke registries at The Children’s Hospital of Philadelphia or The
Children’s Hospital Colorado and contained a synopsis of clinical history, selected
neurovascular imaging, echocardiogram results and thrombophilia testing. Real-life cases
were selected by TB & RI from Children’s Hospital of Philadelphia or Children’s Hospital
Colorado to represent a broad range of stroke etiologies including cardio-embolic,
intracranial arteriopathy (2 cases), dissection, post-infectious, multiple causes (moyamoya
and cardiac catheterization procedure) and idiopathic. Group 2 was comprised of members
of IPSS who did not participate in Group 1, and responded to a call for volunteers. They
reviewed the same cases via an e-mail survey. Group 2 raters classified the cases in the same
manner as Group 1, via Individual Classification and the CASCADE criteria, but were not
given a training session.
Description of the CASCADE Classification System
The primary CASCADE criteria are presented in Figure 2 and Table 1. The IPSS defines
childhood AIS as follows: (1) neurological deficit of acute onset; (2) radiographic image(s)
(MRI or CT) showing cerebral parenchymal infarct(s) conforming to known arterial
territory(ies) and corresponding to clinical manifestations; and (3) occurring in children 29
days to 18 years of age. The CASCADE criteria are not designed to classify perinatal stroke,
defined as stroke occurring before 29 days of life, which has unique risk factors.27
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The primary CASCADE criteria is based upon anatomic site of disease (Table 1), which
provides the capacity to classify any patient with childhood AIS into a single acute primary
category at the time of initial diagnosis (within 1 month of presentation). Standardized
definitions for vascular lesions are provided in Online Table 1a.
The classification at presentation is based upon the location and nature of any identifiable
anatomic abnormality involving the heart, the great vessels in the neck, or the intracranial
vessels that could explain AIS in an individual patient (Figure 2). It is based upon the
investigator’s assessment of the anatomic site of disease after interpreting the results of the
following clinical data: echocardiogram, vascular imaging (MRA, CTA and/or conventional
angiogram), and pattern of anatomic distribution of infarct as demonstrated by MRI or CT,
and clinical history.
There are wide variations in vascular imaging capabilities, algorithms, and interpretation
across medical centers -- and these can change over time. We designed this system to be
applicable regardless of the specific imaging modality or techniques used in the evaluation
of an individual patient. For the purposes of this classification system, CTA and MRA are
considered an adequate evaluation, while conventional angiogram (CA), when performed, is
considered the gold standard.
In cases with multiple anatomic locations of disease potentially contributing to stroke
mechanism (for example, dissection in a patient with congenital heart disease), the stroke is
classified as multifactorial (and the multiple categories will be recorded). Finally, strokes in
patients with normal cardiac and vascular imaging (that might be viewed as “unknown”), or
strokes with an atypical anatomic etiology (i.e. AIS during an endovascular procedure), are
classified as “other”.
Statistical Methods
The inter-rater reliability was measured among raters for each of the major seven
classification categories represented by the cases. Agreement for Individualized
Classification was defined as those cases which utilized the same or similar nomenclature
within their response, and was inclusive of multiple spellings and/or tenses. If agreement
was uncertain, the responses were reviewed by TB and MT, with agreement being awarded
as a default in uncertain situations. We generated a Kappa-statistic for each of these
categories, utilizing the Fleiss unweighted kappa statistic for multiple raters.28 In addition
95% confidence intervals were determined using the Wald method. Employing the
parameters proposed by Landis and Koch,29 we considered a value above 0.8 to represent
near perfect agreement, a value between 0.61–0.80 substantial agreement, a value 0.41–0.60
moderate agreement, a value 0.21–.40 fair agreement, and a value less than 0.20 slight
agreement.
Results
In Group 1 (with training), six raters provided complete data on all test cases (i.e. raters who
classified all seven subjects for both the CASCADE criteria and individual system). Using
these data from the six raters, we calculated an unweighted Kappa statistic as a measure of
inter-rater reliability. In the seven test cases presented to Group 1, inter-observer agreement
(average over subjects of the % of raters that give the majority score for each subject) and
kappa-statistics are better when using CASCADE criteria (90%, range=4/6 to 6/6 and
κ=0.78, 95% CI=[0.49, 0.94]), as compared to using Individual Classification (64%,
range=1/6 to 6/6 and κ=0.40, 95%CI=[0.11, 0.60]). The pairwise rater kappas for the
CASCADE criteria (i.e. each rater vs. all others) ranged from 0.61 to 1 indicating moderate
to excellent agreement across all raters. In Group 2, 17 untrained raters evaluated the seven
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test cases. inter-observer agreement and kappa-statistics are better when using CASCADE
criteria (82%, range=10/17 to 17/17 and κ=0.61 [0.29, 0.77]), as compared to using
Individual Classification (52%, range=6/17 to 15/17 and κ=0.23[0.03, 0.36]; Table). The
pairwise kappas for the CASCADE criteria ranged from -0.04 to 0.86.
Discussion
The CASCADE criteria offer a novel and unique approach to classification of stroke subtype
in childhood AIS compared to previous efforts. The criteria are derived from a consensus-
based process involving pediatric AIS experts and are comprehensive with respect to
childhood-onset AIS etiologies, and therefore seem more likely to be widely adopted than
previously proposed schemes. In addition, the CASCADE criteria unifies previously
published classification systems with the aim of eliminating terms with overlapping and/or
nonspecific definitions, such as focal cerebral arteriopathy, primary angiitis of the central
nervous system of childhood (cPACNS), transient cerebral arteriopathy and steno-occlusive
arteriopathy.6;15-17 As arteriopathy is associated with increased recurrence risk and adverse
outcomes,8;30 standardizing the nomenclature employed in describing vascular disorders
will be essential to developing risk stratified therapies in childhood AIS.
While the initial kappa-statistic of the CASCADE criteria is encouraging (κ=0.61-0.78), it is
based upon a limited number of raters in an unpowered analysis of few cases. Future efforts
to establish inter-rater reliability and validity are warranted, utilizing larger cohorts,
prospectively collected cases and consistently trained raters. The decreased Kappa found in
Group 2 highlights the need for training to maximize the reliability of the CASCADE
criteria. In addition, the discrepancy between groups may have resulted from Group 1
sharing their answers with each other (although they were asked not to do so) or a
discrepancy between the imaging qualities presented to Group 1 and Group 2. The
importance of imaging quality and the need for training (possibly web-based) prior to
classification should be addressed by future studies of reliability. Finally, construct validity
needs testing, possibly by determining the predictive utility of the CASCADE criteria upon
recurrence risk and clinical outcomes.
A limitation of the system is its reliance upon consensus expert opinion when there is a lack
of evidence-based data. In addition, the primary classification is anatomically based, but has
subcategories which are not purely anatomic. This compromise was reached within the
modified Delphi method in order to include established and accepted clinical definitions-
such as dissection or Takayasu arteritis- within the seven major anatomic categories. Similar
to the initial TOAST classification, the CASCADE criteria provide a starting point for
consensus-based classification in childhood AIS; and has the potential for ongoing
modification as new information about childhood-onset AIS is uncovered.
Additionally, there are many important risk factors that are not related to structural disease
of the heart or blood vessels - such as inflammation, thrombophilias, genetic syndromes,
hemoglobinopathies and infections. Future modifications of the CASCADE criteria will
need to further unify and elaborate classification of these factors in a Secondary
Classification System using the same modified-delphi methods, as well as further test our
ability to revise classification beyond the acute period of childhood AIS. This secondary
classification is under development (Online Table 1b), and will be further defined and
validated in future studies. In addition, a temporal dimension to the criteria (Online Table
1c) is also under development and will classify the natural history of the patient’s vascular
disease as stable, reversible, or progressive, based on follow-up imaging.
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Despite these limitations, this represents the first consensus based classification system,
developed by a large consortium of childhood stroke investigators that is inclusive of all
childhood AIS. These findings suggest that the CASCADE criteria may be particularity
useful in the setting of prospective multicenter studies in childhood-onset AIS, where
standardized training of investigators is feasible.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
CASCADE Criteria Acute Primary Classification – Anatomic Features
Primary Classification – select
one only
Definition
1. Small vessel arteriopathy of
childhood
a. Definitive - Confirmation of the definitive diagnosis of small vessel arteriopathy of childhood
requires multifocal arterial narrowing of small caliber vessels on conventional angiogram
AND evidence of small vessel arteriopathy on biopsy; including evidence of intramural/
vascocentric inflammation of the small muscular arteries, capillaries and/venules on brain
biopsy. Supportive evidence can be obtained from electron microscopy demonstrating
endothelial cell activations and/or tubular reticular inclusions (TRIs). Perivascular de-
myelination and/or gliosis can be found, however specific histological features of other
inflammatory brain diseases of childhood must be absent (i.e. diffuse parenchymal de-
myelination).
b. Radiographic - Confirmation of the radiographic-proven diagnosis of small vessel arteriopathy
of childhood requires multifocal arterial narrowing of small caliber vessels on conventional
angiogram.
c. Biopsy - Confirmation of the biopsy-proven diagnosis of small vessel arteriopathy of
childhood requires evidence of small vessel arteriopathy on biopsy; including evidence of
intramural/vascocentric inflammation of the small muscular arteries, capillaries and/venules
on brain biopsy. Supportive evidence can be obtained from electron microscopy
demonstrating endothelial cell activations and/or tubular reticular inclusions (TRIs).
Perivascular de-myelination and/or gliosis can be found, however specific histological
features of other inflammatory brain diseases of childhood have to be absent (i.e. diffuse
parenchymal de-myelination).
d. Probable – Suspected small vessel arteriopathy is based upon a small vessel distribution of
infarct (without another identified etiology), non-invasive imaging and/or a known disease
process associated with small vessel arteriopathy (i.e. meningitis or lupus)
2. Unilateral focal cerebral
arteriopathy of childhood (FCA)
a. Anterior Circulation with collaterals (would include some types of possible moyamoya and
some patients with progressive cPACNS)) - Confirmation of the diagnosis requires MRA,
CTA or CA displaying both: (1) unilateral stenosis or vessel irregularity of a large intracranial
artery (ICA, MCA, ACA) supplying the territory of infarct, and (2) evidence of an excessive
collateral network of vessels distal to the occluded artery.
b. Anterior Circulation without collaterals (would include conditions such as transient cerebral
arteriopathy, post-varicella arteriopathy, and large vessel childhood primary angiitis of the
central nervous system)16;17;24 - Confirmation of the diagnosis requires MRA, CTA or CA
displaying both: (1) unilateral stenosis or vessel irregularity of a large intracranial artery (ICA,
MCA, ACA) supplying the territory of infarct, and (2) no evidence of excessive collateral
network of vessels distal to the occluded artery.
c. Posterior Circulation (would include conditions such as basilar artery stenosis) - Confirmation
of the diagnosis of focal cerebral arteriopathy within the cerebral posterior circulation requires
MRA, CTA or CA displaying unilateral stenosis or vessel irregularity of a large intracranial
artery (PCA, basilar or vertebral) supplying the territory of infarct and not meeting definition
of dissection.
d. Other – such as congenital anomaly
3. Bilateral cerebral arteriopathy
of childhood
a. with collaterals (would include conditions such as moyamoya or fibromuscular dysplasia
(FMD)) - Confirmation of the diagnosis requires MRA, CTA or CA showing (1) bilateral
stenosis or vessel irregularity of a large intracranial artery (ICA, MCA, ACA, PCA) supplying
the territory of infarct, and; (2) evidence of excessive collateral network of vessels distal to the
occluded arteries.
b. without collaterals (would include some types of possible moyamoya) - Confirmation of the
diagnosis of requires MRA, CTA or CA showing (1) bilateral stenosis or vessel irregularity of
a large intracranial artery (ICA, MCA, ACA, PCA) supplying the territory of infarct, and; (2)
no evidence of excessive collateral network of vessels distal to the occluded arteries.
c. Other – such as congenital anomaly
4. Aortic/Cervical Arteriopathy a. Dissection- Confirmation of the diagnosis of intracranial or cervical arterial dissection
requires CTA, MRI/MRA or CA with one of the following three patterns:
1. angiographic findings of a double lumen, intimal flap, or pseudo aneurysm, or, on
axial T1 fat saturation MRI images, a “bright crescent sign” in the arterial wall;
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Primary Classification – select
one only
Definition
2. the sequence of cervical or cranial trauma, or neck pain, or head pain less than 6
weeks preceding angiographic findings of segmental arterial stenosis (or
occlusion) located in the cervical arteries;
3. angiographic segmental stenosis (or occlusion) of the vertebral artery at the level
of the C2 vertebral body, even without known traumatic history. (adapted from
Sebire et al., 2004)16
b. Takayasu arteritis (TA) - Confirmation of the diagnosis of Takayasu arteritis (TA) requires
angiographic abnormalities (CA, CTA or MRA) of the aorta or its major branches (mandatory
criterion) PLUS at least one of the following four features:
• Decreased peripheral artery pulse(s) and /or claudication of the extremities
• Blood pressure difference >=10mmHg
• Bruits over aorta or its major branches
• Hypertension (related to childhood normative data)25
c. Other – such as congenital anomaly or cervical (FMD)
5. Cardio-embolic a. Definite: High-risk for cardiac source of cerebral embolism (such as congenital heart disease
with abnormal cardiac function, arrhythmia or endocarditis), or cardiac procedure within
30days of stroke AND territory of large/medium sized cerebral artery or >1 arterial territory,
may be large and/or hemorrhagic.
b. Probable: >1 arterial territory, may be large and/or hemorrhagic in a child without another
identifiable etiology AND one of the following:
1. PFO with right-to left shunt or other subtle cardiac anomaly
2. Occlusion: A discrete and abrupt blockage of an artery consistent with a clot,
without any surrounding irregularity or stenosis suggestive of arteriopathy.
(Modified from Wraige et al, 2005; and Ay et al, 2007)15;26
6. Other a. Undetermined etiology – etiology unclear despite complete workup (including
echocardiogram, MRI and vascular imaging of head and neck)
b. Other (i.e. – other location of identifiable disease that cannot be classified)
7. Multi-factorial Greater than 1 anatomic site of disease (i.e. patients who have more than one of the primary classifications
and in whom we are unable to determine the predominant site of disease.
(Modified from Sebire et al., 2004; & Wraige et al, 2005)15;16
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